Literature DB >> 11071110

Asymmetric cortico-cortical inhibition in patients with progressive limb-kinetic apraxia.

Y Okuma1, T Urabe, H Mochizuki, H Miwa, Y Shimo, H Mori, Y Mizuno.   

Abstract

OBJECTIVES: To evaluate the activity of cortico-cortical (intracortical) inhibitory circuits within the motor cortex in patients with progressive asymmetric limb-kinetic apraxia.
MATERIALS AND METHODS: We studied 4 patients with progressive limb-kinetic apraxia whose clinical diagnosis was corticobasal degeneration (CBD) and 7 control subjects. Cortico-cortical inhibition was measured using the technique of double pulse transcranial magnetic stimulation over the motor cortex. The effects of conditioning stimuli on the test responses were examined.
RESULTS: In the normal control subjects, the conditioning magnetic stimulus suppressed motor evoked responses to the test stimulus at interstimulus intervals of 1 to 5 ms. This inhibition was significantly diminished on the affected side of the patients, but it was normal on the less affected side.
CONCLUSION: Disruption of intracortical inhibitory circuits in the motor cortex may, at least in part, be related to severe limb clumsiness in the patients with progressive limb-kinetic apraxia.

Entities:  

Mesh:

Year:  2000        PMID: 11071110     DOI: 10.1034/j.1600-0404.2000.102004244.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

Review 1.  Neurophysiology and neurochemistry of corticobasal syndrome.

Authors:  Aditya A Murgai; Mandar S Jog
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

2.  An unusual cause of dementia: essential diagnostic elements of corticobasal degeneration-a case report and review of the literature.

Authors:  F Mastrolilli; A Benvenga; L Di Biase; F Giambattistelli; L Trotta; G Salomone; L Quintiliani; D Landi; J M Melgari; F Vernieri
Journal:  Int J Alzheimers Dis       Date:  2011-07-12

3.  Apraxia and motor dysfunction in corticobasal syndrome.

Authors:  James R Burrell; Michael Hornberger; Steve Vucic; Matthew C Kiernan; John R Hodges
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.